[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CH603560A5 - - Google Patents

Info

Publication number
CH603560A5
CH603560A5 CH1425877A CH1425877A CH603560A5 CH 603560 A5 CH603560 A5 CH 603560A5 CH 1425877 A CH1425877 A CH 1425877A CH 1425877 A CH1425877 A CH 1425877A CH 603560 A5 CH603560 A5 CH 603560A5
Authority
CH
Switzerland
Application number
CH1425877A
Inventor
Hans Dr Wissmann
Rolf Dr Geiger
Wolfgang Dr Koenig
Hansjoerg Dr Kruse
Karl Dr Seeger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH603560A5 publication Critical patent/CH603560A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH1425877A 1973-08-25 1974-08-23 CH603560A5 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2343035A DE2343035C2 (de) 1973-08-25 1973-08-25 Pyroglutamyl-histidyl-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2416428A DE2416428C2 (de) 1973-08-25 1974-04-04 Pyroglutamyl-histidyl-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH603560A5 true CH603560A5 (xx) 1978-08-31

Family

ID=25765691

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1425877A CH603560A5 (xx) 1973-08-25 1974-08-23
CH1152674A CH603558A5 (xx) 1973-08-25 1974-08-23

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1152674A CH603558A5 (xx) 1973-08-25 1974-08-23

Country Status (12)

Country Link
US (1) US3931139A (xx)
JP (1) JPS5756467B2 (xx)
BE (1) BE819198A (xx)
CA (1) CA1029369A (xx)
CH (2) CH603560A5 (xx)
DE (2) DE2343035C2 (xx)
DK (1) DK452274A (xx)
FR (1) FR2241312B1 (xx)
GB (1) GB1463190A (xx)
IE (1) IE39766B1 (xx)
LU (1) LU70783A1 (xx)
NL (1) NL7411111A (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4125605A (en) * 1977-10-19 1978-11-14 The United States Government Method of employing oral TRH
US4215110A (en) * 1978-09-22 1980-07-29 Merck & Co., Inc. Method of treating hypertension
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
US4818531A (en) * 1985-02-06 1989-04-04 Eli Lilly And Company Growth hormone and thyroid hormone
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
JP2007536369A (ja) * 2004-05-06 2007-12-13 ファイザー・インク プロリン及びモルホリン誘導体の新規化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725380A (en) * 1969-04-05 1973-04-03 Hoechst Ag Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
BE754343A (fr) * 1969-08-01 1971-02-03 Hoechst Ag Procede de preparation de peptides

Also Published As

Publication number Publication date
CA1029369A (en) 1978-04-11
LU70783A1 (xx) 1976-08-19
IE39766L (en) 1975-02-25
DE2416428C2 (de) 1984-07-26
US3931139A (en) 1976-01-06
DE2416428A1 (de) 1975-10-23
FR2241312A1 (xx) 1975-03-21
FR2241312B1 (xx) 1978-07-21
BE819198A (fr) 1975-02-26
DK452274A (xx) 1975-04-28
DE2343035C2 (de) 1982-04-01
CH603558A5 (xx) 1978-08-31
JPS5070368A (xx) 1975-06-11
JPS5756467B2 (xx) 1982-11-30
NL7411111A (nl) 1975-02-27
DE2343035A1 (de) 1975-03-06
GB1463190A (en) 1977-02-02
AU7259174A (en) 1976-02-26
IE39766B1 (en) 1978-12-20

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU471343B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
AU476714B2 (xx)
FR2241312A1 (xx)
AR201229Q (xx)
AU466283B2 (xx)
AU476696B2 (xx)
AU472848B2 (xx)
AR199451A1 (xx)
AU477823B2 (xx)
AR196382A1 (xx)
AR195948A1 (xx)
AR200256A1 (xx)
AR201432A1 (xx)
AR200885A1 (xx)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased